Gene Symbol | Gene ID | Gene Info |
---|---|---|
OTX2
|
ENSG00000165588.12 | orthodenticle homeobox 2 |
CRX
|
ENSG00000105392.11 | cone-rod homeobox |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_57264264_57264415 | OTX2 | 8027 | 0.169813 | -0.61 | 8.2e-02 | Click! |
chr14_57263392_57263543 | OTX2 | 8899 | 0.168034 | -0.56 | 1.2e-01 | Click! |
chr14_57262189_57262340 | OTX2 | 10102 | 0.166133 | -0.47 | 2.0e-01 | Click! |
chr14_57274823_57275045 | OTX2 | 2232 | 0.254600 | -0.41 | 2.7e-01 | Click! |
chr14_57274493_57274644 | OTX2 | 2187 | 0.259421 | -0.38 | 3.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_43152776_43153425 | 0.71 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
133368 |
0.05 |
chr19_47478570_47478952 | 0.63 |
ENSG00000252071 |
. |
27215 |
0.14 |
chr12_11733022_11733284 | 0.58 |
ENSG00000251747 |
. |
33740 |
0.16 |
chr1_201426596_201426747 | 0.56 |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
11641 |
0.15 |
chr14_53301825_53302222 | 0.53 |
FERMT2 |
fermitin family member 2 |
29216 |
0.15 |
chr20_34489809_34489960 | 0.53 |
ENSG00000201221 |
. |
14303 |
0.13 |
chr17_30068402_30068553 | 0.45 |
ENSG00000202026 |
. |
27705 |
0.19 |
chr15_46162513_46162674 | 0.45 |
SQRDL |
sulfide quinone reductase-like (yeast) |
187855 |
0.03 |
chr6_130645263_130645558 | 0.42 |
SAMD3 |
sterile alpha motif domain containing 3 |
41160 |
0.17 |
chr22_27531516_27531667 | 0.42 |
ENSG00000200443 |
. |
99741 |
0.09 |
chr4_169496141_169496292 | 0.39 |
PALLD |
palladin, cytoskeletal associated protein |
56550 |
0.12 |
chr4_122705792_122706078 | 0.38 |
EXOSC9 |
exosome component 9 |
16537 |
0.14 |
chr5_64493902_64494516 | 0.38 |
ENSG00000207439 |
. |
75013 |
0.12 |
chr4_39525693_39526119 | 0.38 |
UGDH |
UDP-glucose 6-dehydrogenase |
2271 |
0.25 |
chr8_12583298_12583449 | 0.35 |
ENSG00000266206 |
. |
1440 |
0.38 |
chr1_208382716_208382867 | 0.35 |
PLXNA2 |
plexin A2 |
34874 |
0.24 |
chr1_21478340_21478712 | 0.35 |
EIF4G3 |
eukaryotic translation initiation factor 4 gamma, 3 |
22704 |
0.19 |
chr9_16795794_16795945 | 0.35 |
BNC2 |
basonuclin 2 |
36417 |
0.21 |
chr3_170470237_170470470 | 0.35 |
ENSG00000222411 |
. |
89608 |
0.08 |
chr11_19420172_19420323 | 0.35 |
ENSG00000200687 |
. |
3281 |
0.25 |
chr11_82690749_82690900 | 0.35 |
PRCP |
prolylcarboxypeptidase (angiotensinase C) |
9198 |
0.18 |
chr14_80050698_80050849 | 0.34 |
RP11-242P2.2 |
|
48881 |
0.19 |
chr14_69544397_69544681 | 0.34 |
ENSG00000206768 |
. |
66131 |
0.1 |
chr11_19222231_19222783 | 0.34 |
CSRP3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
1082 |
0.5 |
chr12_1427689_1428011 | 0.34 |
RP5-951N9.2 |
|
67149 |
0.11 |
chr6_82476723_82477129 | 0.34 |
ENSG00000206886 |
. |
3185 |
0.27 |
chr5_148352238_148352777 | 0.34 |
RP11-44B19.1 |
|
2604 |
0.3 |
chr5_81460698_81461288 | 0.33 |
ENSG00000265684 |
. |
86747 |
0.08 |
chr1_67397953_67399117 | 0.33 |
MIER1 |
mesoderm induction early response 1, transcriptional regulator |
2609 |
0.29 |
chr17_73690444_73690713 | 0.33 |
SAP30BP |
SAP30 binding protein |
1952 |
0.18 |
chr1_86020329_86020665 | 0.33 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
23436 |
0.17 |
chr5_95004855_95005067 | 0.32 |
SPATA9 |
spermatogenesis associated 9 |
13699 |
0.16 |
chr2_28497749_28498516 | 0.32 |
AC093690.1 |
|
35194 |
0.19 |
chr5_159305915_159306327 | 0.32 |
ADRA1B |
adrenoceptor alpha 1B |
37669 |
0.2 |
chr8_97603049_97603490 | 0.32 |
SDC2 |
syndecan 2 |
4654 |
0.31 |
chr1_171096536_171096687 | 0.31 |
FMO6P |
flavin containing monooxygenase 6 pseudogene |
10630 |
0.16 |
chr5_64500241_64500433 | 0.31 |
ENSG00000207439 |
. |
81141 |
0.11 |
chr1_59481843_59482033 | 0.31 |
JUN |
jun proto-oncogene |
232153 |
0.02 |
chr12_110493934_110494306 | 0.31 |
C12orf76 |
chromosome 12 open reading frame 76 |
7030 |
0.2 |
chr5_57134395_57134546 | 0.31 |
ENSG00000266864 |
. |
34403 |
0.24 |
chr22_36369506_36369746 | 0.31 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
11912 |
0.28 |
chr2_159996739_159997187 | 0.31 |
ENSG00000202029 |
. |
113309 |
0.06 |
chr8_119017458_119017609 | 0.31 |
EXT1 |
exostosin glycosyltransferase 1 |
105120 |
0.08 |
chr2_206577775_206577938 | 0.30 |
NRP2 |
neuropilin 2 |
29841 |
0.21 |
chr10_34393778_34393929 | 0.30 |
ENSG00000199200 |
. |
97149 |
0.09 |
chr10_35021138_35021390 | 0.30 |
PARD3 |
par-3 family cell polarity regulator |
82985 |
0.1 |
chr19_43493188_43493339 | 0.30 |
PSG11 |
pregnancy specific beta-1-glycoprotein 11 |
37337 |
0.15 |
chr5_34487773_34488055 | 0.30 |
RAI14 |
retinoic acid induced 14 |
168428 |
0.03 |
chr6_35393359_35394053 | 0.30 |
FANCE |
Fanconi anemia, complementation group E |
26432 |
0.15 |
chr8_10657129_10657397 | 0.30 |
ENSG00000252565 |
. |
15698 |
0.15 |
chr6_110417870_110418143 | 0.30 |
WASF1 |
WAS protein family, member 1 |
82846 |
0.09 |
chr9_14271441_14271727 | 0.29 |
NFIB |
nuclear factor I/B |
36428 |
0.2 |
chr2_162949372_162949523 | 0.29 |
DPP4 |
dipeptidyl-peptidase 4 |
18395 |
0.18 |
chr11_130642757_130642947 | 0.29 |
C11orf44 |
chromosome 11 open reading frame 44 |
100001 |
0.08 |
chr11_86447090_86447241 | 0.29 |
PRSS23 |
protease, serine, 23 |
54936 |
0.15 |
chr8_37783052_37783203 | 0.29 |
GOT1L1 |
glutamic-oxaloacetic transaminase 1-like 1 |
11204 |
0.13 |
chr9_74299304_74300206 | 0.29 |
TMEM2 |
transmembrane protein 2 |
20093 |
0.28 |
chr18_68088910_68089061 | 0.28 |
ENSG00000264059 |
. |
59526 |
0.13 |
chr15_35988877_35989028 | 0.28 |
DPH6 |
diphthamine biosynthesis 6 |
150559 |
0.05 |
chr12_13278087_13278467 | 0.28 |
GSG1 |
germ cell associated 1 |
21658 |
0.19 |
chrX_12378398_12378549 | 0.28 |
FRMPD4-AS1 |
FRMPD4 antisense RNA 1 |
14779 |
0.29 |
chr14_69013976_69014127 | 0.28 |
CTD-2325P2.4 |
|
81111 |
0.1 |
chr16_69098691_69098842 | 0.28 |
HAS3 |
hyaluronan synthase 3 |
40701 |
0.11 |
chr16_66652366_66652517 | 0.28 |
CMTM3 |
CKLF-like MARVEL transmembrane domain containing 3 |
13017 |
0.11 |
chr1_52024489_52024927 | 0.28 |
OSBPL9 |
oxysterol binding protein-like 9 |
18143 |
0.15 |
chr17_66755524_66755734 | 0.28 |
ENSG00000263690 |
. |
7071 |
0.3 |
chr10_3570543_3570694 | 0.28 |
RP11-184A2.3 |
|
222641 |
0.02 |
chr9_14251628_14251779 | 0.28 |
NFIB |
nuclear factor I/B |
56309 |
0.15 |
chr8_104117274_104117548 | 0.28 |
ENSG00000265667 |
. |
12462 |
0.13 |
chr2_196440572_196441282 | 0.28 |
SLC39A10 |
solute carrier family 39 (zinc transporter), member 10 |
226 |
0.96 |
chr2_227289868_227290019 | 0.27 |
ENSG00000263363 |
. |
233566 |
0.02 |
chr12_110388287_110388838 | 0.27 |
GIT2 |
G protein-coupled receptor kinase interacting ArfGAP 2 |
45467 |
0.11 |
chr6_1575312_1575463 | 0.27 |
FOXC1 |
forkhead box C1 |
35294 |
0.21 |
chr5_169180771_169181008 | 0.27 |
DOCK2 |
dedicator of cytokinesis 2 |
5832 |
0.26 |
chr2_43496469_43496754 | 0.27 |
AC010883.5 |
|
39899 |
0.17 |
chr11_108786966_108787117 | 0.27 |
ENSG00000201243 |
. |
89203 |
0.1 |
chr5_57032113_57032264 | 0.27 |
ENSG00000221195 |
. |
93375 |
0.09 |
chr3_124849030_124849181 | 0.27 |
SLC12A8 |
solute carrier family 12, member 8 |
9407 |
0.17 |
chr12_66341786_66341937 | 0.27 |
RP11-366L20.3 |
|
398 |
0.86 |
chr9_111396759_111396910 | 0.27 |
ACTL7B |
actin-like 7B |
222405 |
0.02 |
chr16_11295567_11296301 | 0.27 |
RMI2 |
RecQ mediated genome instability 2 |
47572 |
0.08 |
chr6_38230519_38230766 | 0.27 |
ENSG00000200706 |
. |
55592 |
0.15 |
chr1_30185013_30185164 | 0.27 |
ENSG00000221126 |
. |
67563 |
0.14 |
chr1_158029342_158029493 | 0.27 |
KIRREL |
kin of IRRE like (Drosophila) |
27053 |
0.18 |
chr2_231481752_231482027 | 0.27 |
ENSG00000199791 |
. |
30053 |
0.17 |
chr10_131821141_131821577 | 0.27 |
EBF3 |
early B-cell factor 3 |
59254 |
0.15 |
chr3_149469081_149469660 | 0.27 |
COMMD2 |
COMM domain containing 2 |
916 |
0.55 |
chr10_33505911_33506062 | 0.27 |
NRP1 |
neuropilin 1 |
3497 |
0.27 |
chr2_75120069_75120220 | 0.27 |
HK2 |
hexokinase 2 |
57847 |
0.12 |
chr3_174156335_174156660 | 0.27 |
NAALADL2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
2280 |
0.47 |
chr17_79532915_79533078 | 0.27 |
NPLOC4 |
nuclear protein localization 4 homolog (S. cerevisiae) |
632 |
0.54 |
chr9_84173660_84173811 | 0.27 |
TLE1 |
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
54702 |
0.17 |
chr2_200274877_200275028 | 0.26 |
SATB2 |
SATB homeobox 2 |
45859 |
0.16 |
chr9_117715769_117716310 | 0.26 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
23342 |
0.24 |
chr12_53693833_53694662 | 0.26 |
RP11-680A11.5 |
|
149 |
0.73 |
chr6_43088179_43088500 | 0.26 |
PTK7 |
protein tyrosine kinase 7 |
9990 |
0.12 |
chr1_181047003_181047287 | 0.26 |
IER5 |
immediate early response 5 |
10493 |
0.21 |
chr4_129149985_129150136 | 0.26 |
PGRMC2 |
progesterone receptor membrane component 2 |
44156 |
0.2 |
chr3_111480055_111480487 | 0.26 |
PHLDB2 |
pleckstrin homology-like domain, family B, member 2 |
28927 |
0.2 |
chr15_40289924_40290075 | 0.26 |
EIF2AK4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
32595 |
0.12 |
chr4_152666058_152666209 | 0.26 |
PET112 |
PET112 homolog (yeast) |
16004 |
0.24 |
chr2_160816916_160817067 | 0.26 |
LY75-CD302 |
LY75-CD302 readthrough |
55770 |
0.13 |
chr4_171593437_171593770 | 0.26 |
ENSG00000251961 |
. |
219015 |
0.02 |
chr12_66262478_66262882 | 0.26 |
ENSG00000211577 |
. |
10887 |
0.18 |
chr5_39093457_39093608 | 0.26 |
AC008964.1 |
|
11826 |
0.23 |
chr2_183457874_183458025 | 0.26 |
PDE1A |
phosphodiesterase 1A, calmodulin-dependent |
70484 |
0.12 |
chr2_45926277_45926449 | 0.26 |
U51244.2 |
|
23748 |
0.22 |
chr16_11098719_11098870 | 0.26 |
CLEC16A |
C-type lectin domain family 16, member A |
60356 |
0.08 |
chr1_117690204_117690355 | 0.26 |
TRIM45 |
tripartite motif containing 45 |
25070 |
0.15 |
chr1_99922703_99922854 | 0.26 |
LPPR4 |
Lipid phosphate phosphatase-related protein type 4 |
158358 |
0.04 |
chr1_85805501_85805652 | 0.26 |
ENSG00000264380 |
. |
55283 |
0.09 |
chr11_67979238_67979938 | 0.26 |
SUV420H1 |
suppressor of variegation 4-20 homolog 1 (Drosophila) |
633 |
0.74 |
chr4_77956814_77956965 | 0.25 |
SEPT11 |
septin 11 |
7019 |
0.23 |
chr15_99994749_99995202 | 0.25 |
MEF2A |
myocyte enhancer factor 2A |
22395 |
0.18 |
chr6_3517760_3517987 | 0.25 |
SLC22A23 |
solute carrier family 22, member 23 |
60617 |
0.14 |
chr1_223584357_223584508 | 0.25 |
C1orf65 |
chromosome 1 open reading frame 65 |
17717 |
0.2 |
chr5_156943457_156943608 | 0.25 |
ADAM19 |
ADAM metallopeptidase domain 19 |
13702 |
0.17 |
chr10_81923875_81924026 | 0.25 |
ANXA11 |
annexin A11 |
2182 |
0.32 |
chr8_98941895_98942046 | 0.25 |
MATN2 |
matrilin 2 |
1599 |
0.45 |
chr12_71040955_71041106 | 0.25 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
9810 |
0.28 |
chr16_88836823_88837632 | 0.25 |
PIEZO1 |
piezo-type mechanosensitive ion channel component 1 |
14392 |
0.08 |
chr14_85937883_85938084 | 0.25 |
RP11-497E19.2 |
Uncharacterized protein |
56960 |
0.15 |
chr15_74880720_74881033 | 0.25 |
CLK3 |
CDC-like kinase 3 |
19837 |
0.14 |
chr12_64400725_64400876 | 0.25 |
SRGAP1 |
SLIT-ROBO Rho GTPase activating protein 1 |
24495 |
0.2 |
chr11_131783724_131783875 | 0.25 |
NTM |
neurotrimin |
2437 |
0.34 |
chr14_55242379_55242669 | 0.25 |
SAMD4A |
sterile alpha motif domain containing 4A |
20973 |
0.23 |
chr16_30724842_30725097 | 0.25 |
ENSG00000206755 |
. |
3111 |
0.11 |
chr17_40481304_40481455 | 0.25 |
STAT5A |
signal transducer and activator of transcription 5A |
23191 |
0.11 |
chr10_33418933_33419614 | 0.25 |
ENSG00000263576 |
. |
31709 |
0.18 |
chr3_185450728_185450956 | 0.25 |
C3orf65 |
chromosome 3 open reading frame 65 |
19762 |
0.2 |
chr1_208293570_208293721 | 0.25 |
PLXNA2 |
plexin A2 |
124020 |
0.06 |
chr1_224716594_224716745 | 0.25 |
RP11-100E13.1 |
|
87253 |
0.07 |
chr3_69813399_69813761 | 0.25 |
MITF |
microphthalmia-associated transcription factor |
618 |
0.78 |
chr1_61427090_61427390 | 0.25 |
RP4-668G5.1 |
|
8719 |
0.29 |
chr9_37943494_37943645 | 0.25 |
ENSG00000251745 |
. |
6804 |
0.24 |
chr5_72665716_72665867 | 0.25 |
FOXD1 |
forkhead box D1 |
78561 |
0.09 |
chr5_169002894_169003181 | 0.25 |
SPDL1 |
spindle apparatus coiled-coil protein 1 |
7601 |
0.23 |
chr2_188256029_188256180 | 0.25 |
CALCRL |
calcitonin receptor-like |
56875 |
0.15 |
chr3_105078554_105078705 | 0.25 |
ALCAM |
activated leukocyte cell adhesion molecule |
7124 |
0.35 |
chr7_82434629_82434780 | 0.24 |
PCLO |
piccolo presynaptic cytomatrix protein |
145360 |
0.05 |
chr9_73518177_73518328 | 0.24 |
TRPM3 |
transient receptor potential cation channel, subfamily M, member 3 |
34278 |
0.22 |
chr2_235213914_235214065 | 0.24 |
ARL4C |
ADP-ribosylation factor-like 4C |
191255 |
0.03 |
chr2_217180660_217180876 | 0.24 |
AC069155.1 |
|
12720 |
0.18 |
chr6_26103334_26103549 | 0.24 |
HIST1H4C |
histone cluster 1, H4c |
663 |
0.44 |
chr7_116417479_116417780 | 0.24 |
MET |
met proto-oncogene |
400 |
0.88 |
chr10_128613233_128613384 | 0.24 |
ENSG00000202487 |
. |
3932 |
0.29 |
chr4_13478395_13478680 | 0.24 |
RAB28 |
RAB28, member RAS oncogene family |
2568 |
0.38 |
chr6_52376418_52376603 | 0.24 |
TRAM2 |
translocation associated membrane protein 2 |
65203 |
0.11 |
chr15_39481396_39481547 | 0.24 |
C15orf54 |
chromosome 15 open reading frame 54 |
61414 |
0.14 |
chr4_152596771_152596922 | 0.24 |
RP11-164P12.3 |
|
1211 |
0.5 |
chr17_39215738_39215889 | 0.24 |
KRTAP2-3 |
keratin associated protein 2-3 |
531 |
0.48 |
chr12_52182216_52182367 | 0.24 |
AC068987.1 |
HCG1997999; cDNA FLJ33996 fis, clone DFNES2008881 |
21498 |
0.2 |
chr5_180213979_180214228 | 0.24 |
CTC-205M6.5 |
|
766 |
0.61 |
chr10_13981087_13981238 | 0.24 |
FRMD4A |
FERM domain containing 4A |
33207 |
0.19 |
chr10_30236708_30236859 | 0.24 |
KIAA1462 |
KIAA1462 |
111670 |
0.07 |
chr17_2082426_2082658 | 0.24 |
SMG6 |
SMG6 nonsense mediated mRNA decay factor |
6070 |
0.13 |
chr13_95740200_95740570 | 0.24 |
ENSG00000252335 |
. |
68896 |
0.12 |
chr16_70741421_70741612 | 0.24 |
VAC14 |
Vac14 homolog (S. cerevisiae) |
7368 |
0.15 |
chr4_77468211_77468426 | 0.24 |
ENSG00000207307 |
. |
14838 |
0.16 |
chr9_133640945_133641435 | 0.24 |
ABL1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
51823 |
0.13 |
chr8_41548916_41549067 | 0.24 |
ANK1 |
ankyrin 1, erythrocytic |
14706 |
0.15 |
chr4_187767041_187767192 | 0.24 |
ENSG00000252382 |
. |
11494 |
0.3 |
chr12_77425923_77426193 | 0.24 |
E2F7 |
E2F transcription factor 7 |
18468 |
0.27 |
chr14_61492762_61493358 | 0.24 |
SLC38A6 |
solute carrier family 38, member 6 |
16808 |
0.21 |
chr1_16505237_16505388 | 0.24 |
ARHGEF19-AS1 |
ARHGEF19 antisense RNA 1 |
19037 |
0.1 |
chr1_85950376_85950527 | 0.24 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
19624 |
0.21 |
chr6_14286162_14286313 | 0.24 |
ENSG00000238987 |
. |
129544 |
0.06 |
chr1_94429653_94429804 | 0.24 |
ABCA4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
47453 |
0.13 |
chrX_20085662_20085960 | 0.24 |
MAP7D2 |
MAP7 domain containing 2 |
10916 |
0.18 |
chr7_81476151_81476440 | 0.24 |
ENSG00000263416 |
. |
73291 |
0.11 |
chr3_52205760_52205911 | 0.23 |
POC1A |
POC1 centriolar protein A |
17129 |
0.12 |
chr5_98396799_98396950 | 0.23 |
ENSG00000200351 |
. |
124423 |
0.06 |
chr1_200341478_200341663 | 0.23 |
ZNF281 |
zinc finger protein 281 |
37550 |
0.22 |
chr5_114738428_114738579 | 0.23 |
CCDC112 |
coiled-coil domain containing 112 |
105975 |
0.06 |
chr21_18864726_18865102 | 0.23 |
ENSG00000266195 |
. |
13857 |
0.15 |
chr6_11195366_11195517 | 0.23 |
RP3-510L9.1 |
|
21756 |
0.19 |
chr4_122613058_122613356 | 0.23 |
ANXA5 |
annexin A5 |
4910 |
0.26 |
chr8_123671514_123671802 | 0.23 |
ENSG00000238901 |
. |
11872 |
0.28 |
chr5_121518729_121518882 | 0.23 |
CTC-441N14.1 |
|
27095 |
0.17 |
chr1_146638682_146638833 | 0.23 |
PRKAB2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
5289 |
0.17 |
chr19_49554011_49554162 | 0.23 |
CGB8 |
chorionic gonadotropin, beta polypeptide 8 |
1686 |
0.12 |
chr18_46069398_46069549 | 0.23 |
CTIF |
CBP80/20-dependent translation initiation factor |
3007 |
0.33 |
chr13_110492993_110493226 | 0.23 |
IRS2 |
insulin receptor substrate 2 |
54194 |
0.15 |
chr8_18992583_18992734 | 0.23 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
50418 |
0.18 |
chr1_33809231_33809577 | 0.23 |
PHC2 |
polyhomeotic homolog 2 (Drosophila) |
6082 |
0.12 |
chr9_127162086_127162596 | 0.23 |
PSMB7 |
proteasome (prosome, macropain) subunit, beta type, 7 |
15377 |
0.19 |
chr1_12524294_12524445 | 0.23 |
VPS13D |
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
626 |
0.77 |
chr1_84719853_84720004 | 0.23 |
ENSG00000199959 |
. |
23076 |
0.21 |
chr8_49292717_49292868 | 0.23 |
ENSG00000252710 |
. |
72202 |
0.13 |
chr3_185463874_185464186 | 0.23 |
ENSG00000265470 |
. |
21662 |
0.19 |
chr16_68333106_68333257 | 0.23 |
SLC7A6OS |
solute carrier family 7, member 6 opposite strand |
4951 |
0.09 |
chr1_54801806_54802163 | 0.23 |
RP5-997D24.3 |
|
50906 |
0.12 |
chr17_48138498_48138649 | 0.23 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
4769 |
0.15 |
chr1_178509729_178509880 | 0.23 |
C1orf220 |
chromosome 1 open reading frame 220 |
2083 |
0.23 |
chr13_27193375_27193609 | 0.23 |
WASF3-AS1 |
WASF3 antisense RNA 1 |
22009 |
0.24 |
chr15_64721787_64722615 | 0.23 |
TRIP4 |
thyroid hormone receptor interactor 4 |
5887 |
0.12 |
chr5_149886580_149886731 | 0.23 |
NDST1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
1019 |
0.53 |
chr3_50138493_50138644 | 0.23 |
RBM5 |
RNA binding motif protein 5 |
10765 |
0.14 |
chr12_13357086_13357299 | 0.23 |
EMP1 |
epithelial membrane protein 1 |
7253 |
0.27 |
chrX_6962695_6962846 | 0.23 |
ENSG00000264268 |
. |
103131 |
0.08 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.4 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.2 | GO:0048343 | paraxial mesodermal cell differentiation(GO:0048342) paraxial mesodermal cell fate commitment(GO:0048343) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.0 | 0.2 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:2000647 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.0 | GO:0060872 | semicircular canal development(GO:0060872) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.2 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.0 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0003170 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0046886 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0003097 | renal water transport(GO:0003097) |
0.0 | 0.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.2 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
0.0 | 0.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.0 | 0.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0046083 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.0 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.0 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.3 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.0 | GO:0060068 | female genitalia morphogenesis(GO:0048807) vagina development(GO:0060068) |
0.0 | 0.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.2 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.3 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.2 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 1.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.4 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0043230 | extracellular organelle(GO:0043230) extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 3.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.0 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.6 | GO:0030016 | myofibril(GO:0030016) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.2 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |